CGMs for Longevity Biohacking: What the Experts Actually Recommend
Top longevity doctors endorse CGMs for healthy adults, but evidence is mixed. Here's what the 2026 device reviews reveal.
20 articles
Top longevity doctors endorse CGMs for healthy adults, but evidence is mixed. Here's what the 2026 device reviews reveal.
Longevity experts endorse short CGM trials for non-diabetics, but RCT evidence remains thin. Here's what the data actually shows.
Expert reviews compare top CGMs for longevity use, but evidence for healthy adults remains limited. Here's what you need to know.
Longevity experts endorse CGMs for metabolic optimization, but RCT evidence in non-diabetics is still thin.
Dexcom G7 tops expert picks for metabolic biohacking, but evidence for non-diabetics remains mixed. Here's what the data says.
Expert reviews of top CGM platforms reveal genuine metabolic insights โ but no proof they extend lifespan in healthy adults.
A head-to-head review of 10 CGM devices for healthy adults, weighing real-world accuracy data against limited longevity evidence.
Continuous glucose monitors are popular in biohacking circles, but direct evidence linking CGM use to extended lifespan remains thin.
Six leading CGM platforms compared on accuracy, evidence quality, and longevity claims โ most fall short of the hype.
A Cochrane review of 37 RCTs finds obesity drugs modestly reduce weight in adolescents, but evidence quality is low and long-term data are absent.
A landmark review reveals how sustained glucocorticoid exposure drives aging biology โ and what can be done about it.
A new framework redefines age-related insulin resistance as a systemic collapse of metabolic resilience spanning muscle, fat, brain, and more.
A Cochrane review of 21 RCTs finds remote pharmacist care may improve adherence and lower blood pressure in NCD patients.
A Circulation review from Harvard proposes the 'target trial framework' to improve how observational data is used to assess cardiovascular device safety and effectiveness.
A Cochrane review of two RCTs finds very low-certainty evidence that IGF-1 neither prevents nor worsens retinopathy of prematurity in extremely preterm infants.
A new review reveals how epithelial-to-mesenchymal transition fuels tumor invasion, immune evasion, and drug resistance through dynamic, reversible states.
A new review reframes magnesium as a master regulator of mitochondrial energy, metabolic disease, and biological aging.
A new framework proposes organ-specific biological clocks using multi-omics data to better predict disease onset and aging trajectories.
The British Society of Gastroenterology's expert panel takes stock of 10 years of microbiome advances and where the field is headed.
Burke and Noakes reach surprising common ground on fueling endurance sport, while key disagreements remain unresolved.